In drug resistant cells, XIAP and Survivin expression is upregulated by FOXM1.
XIAP and Survivin levels are inhibited in FOXM1-depleted breast cancer cells.
FOXM1 knockdown results in decreased binding to XIAP and Survivin gene promoters.
In breast cancer patients, FOXM1 is associated with XIAP and Survivin expression.
Co-expression of FOXM1, Survivin, and nuclear XIAP impacts breast cancer survival.